Arrhythmias Detection in a Real World Population

Inclusion Criteria

• •Patient implanted with a Subcutaneous (S)- Ventricular Chamber (VR)- Dual Chamber (DR) - or Cardiac Resynchronization Therapy (CRT) Defibrillator (this study will utilize all the market released CRT-D or VR/DR-ICD systems and leads)
• •Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent
• •Patient must be able to attend all required follow-up visits at the study center for at least 12 months